Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy
S Sánchez-Ramón, JC Ravell, I de la Torre… - Rheumatology …, 2010 - Springer
S Sánchez-Ramón, JC Ravell, I de la Torre, M Montoro, M Rodríguez-Mahou…
Rheumatology international, 2010•SpringerWe report on a 44-year-old woman affected by dermatopolymyositis resistant to
conventional therapies who experienced long-term clinical improvement and remission after
treatment with intravenous polyvalent immunoglobulin in a weekly schedule followed by
rituximab therapy.
conventional therapies who experienced long-term clinical improvement and remission after
treatment with intravenous polyvalent immunoglobulin in a weekly schedule followed by
rituximab therapy.
Abstract
We report on a 44-year-old woman affected by dermatopolymyositis resistant to conventional therapies who experienced long-term clinical improvement and remission after treatment with intravenous polyvalent immunoglobulin in a weekly schedule followed by rituximab therapy.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果